• Skip to primary navigation
  • Skip to main content
  • Skip to primary sidebar
MRC Laboratory of Molecular Biology

MRC Laboratory of Molecular Biology

One of the world's leading research institutes, our scientists are working to advance understanding of biological processes at the molecular level - providing the knowledge needed to solve key problems in human health.

  • Home
  • About LMB
  • Research
  • Research Groups
  • Students
  • Recruitment
  • Life at the LMB
  • Achievements
  • News & Events
Home > Insight on Research > Understanding how toxins can affect the mechanism of the ribosome

Understanding how toxins can affect the mechanism of the ribosome

Published on 18 October, 2010

Dr Venki Ramakrishnan’s lab from the LMB’s Structural Studies Division have uncovered the molecular mechanism by which toxins such as ricin and alpha-sarcin inhibit protein synthesis in cells. It was known that these toxins act on a highly conserved RNA loop in the ribosome, the molecular machinery which synthesises proteins in both prokaryotic and eukaryotic cells. However, until this time it has not been clear exactly how they prevent protein translation by the ribosome at a molecular level. The toxins modify or cleave the so-called sarcin-ricin loop in the 50S subunit of the ribosome. The latest paper from Venki’s group provides direct evidence for why this loop is so important for the function of the ribosome.

Every stage of translation depends on protein factors that hydrolyse GTP. The recent publication shows that the sarcin-ricin loop plays a crucial role in positioning a catalytic histidine residue in exactly the right position to hydrolyse the GTP molecule, which is an essential step for the ribosome to proceed to the next stage. If this loop is modified (as by ricin) or cleaved (as with other toxins such as alpha-sarcin) the ribosome is unable to trigger this catalysis and remains stuck. The resulting loss of the ability to make proteins kills the affected cell.

The research, which is published in Science, was funded by the Medical Research Council, the Wellcome Trust, the Agouron Institute and the Louis-Jeantet Foundation.

Further references:

Science paper
Venki Ramakrishnan’s Group Page

Primary Sidebar

Search

  • Privacy & Cookies
  • Contact Directory
  • Freedom of Information
  • Site Map
Find Us
©2025 MRC Laboratory of Molecular Biology,
Francis Crick Avenue, Cambridge Biomedical Campus, Cambridge CB2 0QH, UK. 01223 267000

The MRC is part of UK Research and Innovation

Contact Us

This site uses cookies. The LMB may use cookies to analyse how you use our website. We use external analysis systems which may set additional cookies to perform their analysis. These cookies (and any others in use) are detailed in our Privacy and Cookies Policy and are integral to our website. You can delete or disable these cookies in your web browser if you wish, but then our site may not work as it is designed. Ok